The Claim
In patients with coronary artery disease undergoing percutaneous coronary intervention, high-sensitivity C-reactive protein thresholds of 2 mg/L and 3 mg/L demonstrate equivalent predictive accuracy for major adverse cardiac and cerebrovascular events within one year.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
For patients with coronary artery disease who have undergone angioplasty, measuring C-reactive protein at 2 mg/L or 3 mg/L predicts the risk of serious heart or brain events within one year with the same level of accuracy.
See the scientific wording
In patients with coronary artery disease undergoing percutaneous coronary intervention, high-sensitivity C-reactive protein thresholds of 2 mg/L and 3 mg/L show similar ability to predict major adverse cardiac and cerebrovascular events within one year, indicating that neither cutoff is clearly superior for risk stratification.
When inflammation in the blood reaches a certain level, it triggers processes that damage blood vessels and increase the chance of clots forming. This damage happens at similar rates whether the inflammation marker is just above 2 mg/L or just above 3 mg/L, so both levels identify the same group of people at high risk for heart attacks or strokes.
What the research says
1 studyFor heart patients getting stents, checking if their CRP level is above 2 or above 3 gives about the same idea of their risk for heart attack or stroke — neither number is clearly better than the other at predicting danger.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.